Shares of Integer Holdings Co. (NYSE:ITGR – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year target price among brokers that have covered the stock in the last year is $133.86.
Several analysts recently commented on ITGR shares. Oppenheimer started coverage on Integer in a research note on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 price target on the stock. Benchmark reaffirmed a “buy” rating and issued a $130.00 price target on shares of Integer in a research note on Friday, August 2nd.
Check Out Our Latest Report on Integer
Insiders Place Their Bets
Hedge Funds Weigh In On Integer
A number of institutional investors and hedge funds have recently bought and sold shares of ITGR. Public Employees Retirement Association of Colorado lifted its stake in shares of Integer by 3,260.1% during the fourth quarter. Public Employees Retirement Association of Colorado now owns 285,439 shares of the medical equipment provider’s stock valued at $28,281,000 after acquiring an additional 276,944 shares during the period. Norges Bank acquired a new position in shares of Integer during the fourth quarter valued at $18,697,000. Driehaus Capital Management LLC lifted its stake in shares of Integer by 62.5% during the second quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider’s stock valued at $40,880,000 after acquiring an additional 135,750 shares during the period. F M Investments LLC acquired a new position in shares of Integer during the second quarter valued at $11,143,000. Finally, Point72 Europe London LLP acquired a new position in shares of Integer during the second quarter valued at $6,241,000. Institutional investors and hedge funds own 99.29% of the company’s stock.
Integer Stock Performance
ITGR opened at $127.09 on Wednesday. The stock has a market cap of $4.26 billion, a PE ratio of 43.98, a P/E/G ratio of 1.81 and a beta of 1.09. The company has a current ratio of 3.29, a quick ratio of 1.96 and a debt-to-equity ratio of 0.73. Integer has a 1 year low of $69.40 and a 1 year high of $131.87. The stock’s 50 day simple moving average is $123.20 and its 200-day simple moving average is $118.83.
Integer (NYSE:ITGR – Get Free Report) last released its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.06. The business had revenue of $436.20 million for the quarter, compared to analysts’ expectations of $437.00 million. Integer had a return on equity of 11.48% and a net margin of 6.31%. Integer’s quarterly revenue was up 9.0% on a year-over-year basis. During the same period in the previous year, the business posted $1.14 earnings per share. Sell-side analysts forecast that Integer will post 5.31 EPS for the current year.
About Integer
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Recommended Stories
- Five stocks we like better than Integer
- What Does a Stock Split Mean?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- The Risks of Owning Bonds
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.